These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27266076)

  • 1. [Diabetic retinopathy treatment and management--current and future regenerative medicine].
    Kamao H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():135-9. PubMed ID: 27266076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status and perspective of regenerative medicine for diabetic nephropathy].
    Matsui S; Osafune K
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():207-11. PubMed ID: 27266089
    [No Abstract]   [Full Text] [Related]  

  • 3. Human induced pluripotent stem cells: the past, present, and future.
    Hussein SM; Nagy K; Nagy A
    Clin Pharmacol Ther; 2011 May; 89(5):741-5. PubMed ID: 21430659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Translational research of cell sheet-based myocardial regeneration therapy].
    Miyagawa S
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):269-71. PubMed ID: 27181720
    [No Abstract]   [Full Text] [Related]  

  • 5. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural course and management of diabetic retinopathy.
    Sheffer A
    Mt Sinai J Med; 1987 Mar; 54(3):228-35. PubMed ID: 3495727
    [No Abstract]   [Full Text] [Related]  

  • 7. Induced pluripotent stem cells in research and therapy.
    Teoh HK; Cheong SK
    Malays J Pathol; 2012 Jun; 34(1):1-13. PubMed ID: 22870592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enthusiasm for induced pluripotent stem cell-based therapies in kidney regeneration.
    Shen WC; Chou YH; Lin SL
    J Formos Med Assoc; 2016 Aug; 115(8):593-4. PubMed ID: 25043507
    [No Abstract]   [Full Text] [Related]  

  • 10. Will it be possible to generate kidney tissue from induced pluripotent stem cells for regenerative therapy?
    Osafune K
    Regen Med; 2014 Jan; 9(1):9-12. PubMed ID: 24351001
    [No Abstract]   [Full Text] [Related]  

  • 11. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
    Cebrian-Serrano A; Stout T; Dinnyes A
    Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A review 53. Regenerative medicine for corneal epithelium].
    Nishida K
    Nippon Ganka Gakkai Zasshi; 2013 Jan; 117(1):69-83. PubMed ID: 23424976
    [No Abstract]   [Full Text] [Related]  

  • 17. Reproductive medicine gets a new tool.
    Ang WX; Toh CX; Ng HH; Loh YH
    J Mol Cell Biol; 2011 Dec; 3(6):320-1. PubMed ID: 22116889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [iPS cells for the generation of cartilage and for regenerative medicine and disease modeling of cartilage diseases].
    Tsumaki N
    Clin Calcium; 2016 Apr; 26(4):587-92. PubMed ID: 27013630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulus-triggered acquisition of pluripotency: a new perspective in reprogramming of differentiated somatic cells].
    Blum HE
    Dtsch Med Wochenschr; 2014 Feb; 139(9):441-3. PubMed ID: 24557999
    [No Abstract]   [Full Text] [Related]  

  • 20. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.